Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2013, Article ID 369807, 4 pages
http://dx.doi.org/10.1155/2013/369807
Case Report

Acute Thyrotoxic Bulbar Myopathy with Encephalopathic Behaviour: An Uncommon Complication of Hyperthyroidism

1John L McClellan Memorial Veterans Hospital, Little Rock, AR, USA
2University of Arkansas Medical Sciences, Little Rock, AR, USA

Received 8 March 2013; Accepted 23 May 2013

Academic Editors: G. Aimaretti, K. Iida, T. Kita, and R. Swaminathan

Copyright © 2013 Neeraja J. Boddu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. Kammer and C. R. Hamilton Jr., “Acute bulbar muscle dysfunction and hyperthyroidism. A study of four cases and review of the literature,” American Journal of Medicine, vol. 56, no. 4, pp. 464–470, 1974. View at Google Scholar · View at Scopus
  2. W.-Y. Chiu, C.-C. Yang, I.-C. Huang, and T.-S. Huang, “Dysphagia as a manifestation of thyrotoxicosis: report of three cases and literature review,” Dysphagia, vol. 19, no. 2, pp. 120–124, 2004. View at Google Scholar · View at Scopus
  3. D. Gaan, “Chronic thyrotoxic myopathy with involvement of respiratory and bulbar muscles,” British Medical Journal, vol. 3, article 415, no. 5562, 1967. View at Google Scholar
  4. R. Weinstein, R. Schwartzman, and G. S. Levey, “Propranolol reversal of bulbar dysfunction and proximal myopathy in hyperthyroidism,” Annals of Internal Medicine, vol. 82, no. 4, pp. 540–541, 1975. View at Google Scholar · View at Scopus
  5. A. Lleo, J. Sanahuja, C. Serrano, R. Rojas, and I. Illa, “Acute bulbar weakness: thyrotoxicosis or myasthenia gravis?” Annals of Neurology, vol. 46, no. 3, pp. 434–435, 1999. View at Google Scholar
  6. I. D. Ramsay, “Muscle dysfunction in hyperthyroidism,” Lancet, vol. 2, no. 7470, pp. 931–934, 1966. View at Google Scholar · View at Scopus
  7. A. W. C. Kung, “Neuromuscular complications of thyrotoxicosis,” Clinical Endocrinology, vol. 67, no. 5, pp. 645–650, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Ramsay, “Thyrotoxic muscle disease,” Postgraduate Medical Journal, vol. 44, no. 511, pp. 385–397, 1968. View at Google Scholar · View at Scopus
  9. J. J. Ravera, J. M. Cervino, G. Fernandez et al., “Two Cases of graves disease with signs of a pyramidal lesion—improvement in neurologic signs during treatment with antithyroid drugs,” The Journal of Clinical Endocrinology & Metabolism, vol. 20, pp. 876–880, 1960. View at Google Scholar
  10. C. Sinclair, J. M. Gilchrist, J. V. Hennessey, and M. Kandula, “Muscle carnitine in hypo- and hyperthyroidism,” Muscle and Nerve, vol. 32, no. 3, pp. 357–359, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Erkintalo, D. Bendahan, J.-P. Mattéi, C. Fabreguettes, P. Vague, and P. J. Cozzone, “Reduced metabolic efficiency of skeletal muscle energetics in hyperthyroid patients evidenced quantitatively by in vivo phosphorus-31 magnetic resonance spectroscopy,” Metabolism, vol. 47, no. 7, pp. 769–776, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Melamed, M. Berman, and S. Lavy, “Posterolateral myelopathy associated with thyrotoxicosis,” The New England Journal of Medicine, vol. 293, no. 15, pp. 778–779, 1975. View at Google Scholar · View at Scopus
  13. S. P. L. Yang, P. H. Wu, B. H. Tey, and C. K. Tan, “A patient with thyroid storm presenting with apathetic thyrotoxicosis and features of meningoencephalitis,” Thyroid, vol. 21, no. 6, pp. 675–678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Garcia and R. H. Fleming, “Reversible corticospinal tract disease due to hyperthyroidism,” Archives of Neurology, vol. 34, no. 10, pp. 647–648, 1977. View at Google Scholar · View at Scopus
  15. M. Fischer, J. E. Mateer, I. Ullrich, and J. A. Gutrecht, “Pyramidal tract deficits and polyneuropathy in hyperthyroidism—combination clinically mimicking amyotrophic lateral sclerosis,” American Journal of Medicine, vol. 78, no. 6, pp. 1041–1044, 1985. View at Google Scholar · View at Scopus
  16. E. M. Chapman and F. Maloof, “Bizarre clinical mainifestations of hyperthyroidism,” The New England Journal of Medicine, vol. 254, pp. 1–5, 1956. View at Google Scholar
  17. P. J. Shaw, D. Bates, and P. Kendall-Taylor, “Hyperthyroidism presenting as pyramidal tract disease,” British Medical Journal, vol. 297, no. 6660, pp. 1395–1396, 1988. View at Google Scholar · View at Scopus
  18. D. Diez, C. Grijota-Martinez, P. Agretti et al., “Thyroid hormone action in the adult brain: gene expression profiling of the effects of single and multiple doses of triiodo-L-thyronine in the rat striatum,” Endocrinology, vol. 149, no. 8, pp. 3989–4000, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Mignarri, S. Rossi, M. Ballerini et al., “Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis,” Journal of Neurology, vol. 258, no. 5, pp. 783–790, 2011. View at Publisher · View at Google Scholar · View at Scopus